Turkmenistan Medical Device Registration: Origin-Country Instructions for Use

1. Key takeaways

The Turkmen documentation list contains an easily overlooked standalone item:

Instructions for use intended for the country where the medical device is manufactured, normally to be provided in a Russian or English version.

In other words: in addition to the version prepared for healthcare institutions in Turkmenistan (the preceding chapter), a separate origin-country version of the instructions for use must be submitted, making two versions in total. The two versions serve different purposes and are reviewed against each other, so they must both be complete documents rather than extracts. For manufacturers accustomed to EU or Chinese documentation practice, this item has no domestic counterpart, and it is precisely the kind of requirement that is discovered late — at the completeness check — if it is not planned from the start of dossier preparation.

The cost of the second version is modest but real: one additional full translation, one additional controlled document in the version management system, and one additional item in the reconciliation work described below. The cost of missing it is much larger, because a dossier gap discovered at acceptance typically costs a full correction cycle and can push the start of substantive review back by weeks. Making the origin-country manual a standing line item on the project checklist is the simplest way to absorb this requirement into normal operations.

2. Legal basis

3. Expert insights

Insight 1: The function of this document is baseline comparison.

What the reviewer receives is the instructions for use actually applied to the product in its country of manufacture. Its purpose is to serve as a comparison baseline against the Turkmen version proposed for approval, confirming that no information has been deleted, no indications have been expanded, and no warnings have been weakened. The document therefore functions as an integrity check on the localization process itself, and the cleanest way to pass it is to make sure the translation is faithful and every divergence from the original is documented.

Insight 2: It reveals a translation-faithfulness review logic.

The coexistence of two versions hands the reviewer a natural comparison tool. If the Turkmen version has fewer indications, fewer contraindications, or fewer warnings than the origin-country version, the difference will be found directly. The lesson is that translation is not rewriting: every omission must have a documented reason. Teams that treat localization as an editorial exercise, trimming content for style or market fit, run directly into this review logic and should re-educate their translation vendors before the dossier is assembled.

Insight 3: The language requirement is Russian or English, not Turkmen.

The list entry explicitly states that this version is in Russian/English. This differs slightly from the three-language option of Turkmen, Russian, and English that applies to other dossier documents. The Chinese original of a Chinese mainland manufacturer must be translated into Russian or English before submission. Note that the translation should be a full rendering of the original manual, including appendices and symbols legends, since partial translations defeat the comparison purpose.

Insight 4: This differs from EU and Chinese practice, so Chinese manufacturers must prepare it deliberately.

Neither EU technical documentation nor Chinese registration dossiers require a standalone origin-country version of the instructions for use. A manufacturer who prepares the file on the basis of domestic or EU experience will be missing this one document. Because the item sits in the completeness check rather than the technical assessment, its absence is discovered late and costs a full resubmission cycle.

Insight 5: Any differences between the two versions must themselves be explainable.

If the manual has been localized for Turkmen conditions — climate, power supply, clinical practice — for example by adding high-temperature storage guidance, the dossier should state the reason for each adjustment, so that localization is not misread as information deletion. A short reconciliation table mapping each difference to its rationale converts this from a risk into a demonstration of diligence. The table also serves the manufacturer internally: it forces the localization team to declare every edit at the moment it is made, when the reason is still known, rather than reconstructing intentions months later during review.

4. Practical recommendations

1. Prepare a separate origin-country version of the instructions for use translated into Russian or English.
2. Build a two-version comparison table comparing indications, contraindications, warnings, and operating steps item by item.
3. State a reason in the dossier for every omission and never delete content without explanation.
4. Flag localized additions separately, identifying them as supplements responding to local conditions.
5. Mark both versions with their version numbers and dates to make the review cross-check easy.

5. Verification checklist

• □ The origin-country version of the instructions for use has been submitted separately (in Russian or English).
• □ A two-version comparison table has been produced (indications, contraindications, warnings, operating steps).
• □ Omitted items have been explained with reasons.
• □ Localized additions have been flagged separately.
• □ Both versions carry the version number and date.

Regulatory information verified as of October 30, 2026. The content cited in this article was cross-checked against the Law of Turkmenistan on the Supply of Medicines No. 319-V of January 12, 2016 and the Regulation on State Registration of Medicines and Medical Devices approved by the Ministry of Health (separate submission of the instructions for use of the country of manufacture, in Russian or English); this item normally does not exist in the EU or Chinese documentation systems, and manufacturers from the Chinese mainland must prepare it separately.

• GRZAN local resources in Turkmenistan: GRZAN supports manufacturers, importers, and authorized representatives by coordinating licensed local import entities and authorized representative resources, covering national registration submissions, the consular legalization chain for documents, sample delivery, liaison with mandatory TDS certification, and customs clearance support.
• Service capabilities: classification assessment, registration pathway selection, preparation of dossiers in the approved national formats, consular legalization and notarization, preparation of test and stability documentation, organization of GMP and ISO 13485 evidence, change procedures and certificate renewal, vigilance and post-market maintenance.
• Contact: info@grzanglobal.com.